Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Neumora Therapeutics, Inc. | Title: SVP Finance & Principal Accounting Officer | Common Stock | 24.4K | $293K | $11.98 | Feb 14, 2024 | Direct |
Neumora Therapeutics, Inc. | Title: SVP Finance & Principal Accounting Officer | Stock Option (Right to Buy) | 41.3K | Feb 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NMRA | Neumora Therapeutics, Inc. | Feb 14, 2024 | 2 | $0 | 4 | Feb 16, 2024 | Title: SVP Finance & Principal Accounting Officer |
NMRA | Neumora Therapeutics, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 18, 2023 | Title: SVP Finance & Principal Accounting Officer; Exhibit 24 - Power of Attorney |